Similar articles for PMID: 20735384

Year	Number of Results
1968	1
1973	1
1975	1
1976	1
1980	1
1981	1
1983	3
1984	2
1985	3
1986	6
1988	2
1989	1
1991	2
1993	3
1994	2
1996	3
1998	1
2000	2
2001	1
2002	2
2004	6
2005	5
2006	4
2007	6
2008	6
2009	9
2010	13
2011	9
2012	11
2013	13
2014	5
2015	4
2016	9
2017	5
2018	4
2019	4
2020	5
2021	5
2022	7
2023	1
2024	0

1

Expression of integrin proteins in non-muscle-invasive bladder cancer: significance of intravesical recurrence after transurethral resection.

Behnsawy HM, Miyake H, Abdalla MA, Sayed MA, Ahmed Ael-F, Fujisawa M. Behnsawy HM, et al. BJU Int. 2011 Jan;107(2):240-6. doi: 10.1111/j.1464-410X.2010.09534.x. Epub 2010 Aug 24. BJU Int. 2011. PMID: 20735384

2

Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: correlation with intravesical recurrence following transurethral resection.

Behnsawy HM, Miyake H, Abdalla MA, Sayed MA, Ahmed Ael-F, Fujisawa M. Behnsawy HM, et al. Urol Oncol. 2011 Sep-Oct;29(5):495-501. doi: 10.1016/j.urolonc.2009.08.002. Epub 2009 Nov 13. Urol Oncol. 2011. PMID: 19914103

3

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF. Karam JA, et al. Urology. 2007 Sep;70(3):482-6. doi: 10.1016/j.urology.2007.05.009. Urology. 2007. PMID: 17905101

4

The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy.

Hellenthal NJ, Ramirez ML, Evans CP, Devere White RW. Hellenthal NJ, et al. BJU Int. 2010 Feb;105(4):485-8. doi: 10.1111/j.1464-410X.2009.08905.x. Epub 2009 Oct 22. BJU Int. 2010. PMID: 19849694

5

Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.

Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H. Huguet J, et al. Eur Urol. 2005 Jul;48(1):53-9; discussion 59. doi: 10.1016/j.eururo.2005.03.021. Epub 2005 Apr 7. Eur Urol. 2005. PMID: 15967252

6

The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.

Solsona E, Iborra I, Rubio J, Casanova J, Almenar S. Solsona E, et al. BJU Int. 2004 Dec;94(9):1258-62. doi: 10.1111/j.1464-410X.2004.05228.x. BJU Int. 2004. PMID: 15610101

7

Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.

Solsona E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S. Solsona E, et al. J Urol. 2002 May;167(5):2007-11. J Urol. 2002. PMID: 11956428

8

[Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].

Li Q, Xu T, Wang XF. Li Q, et al. Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):904-7. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20193328 Clinical Trial. Chinese.

9

[Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].

Huguet J, Gaya JM, Sabaté S, Palou J, Villavicencio H. Huguet J, et al. Actas Urol Esp. 2010 Jan;34(1):63-70. Actas Urol Esp. 2010. PMID: 20223134 Spanish.

10

Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.

Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF. Tilki D, et al. J Urol. 2010 May;183(5):1757-63. doi: 10.1016/j.juro.2010.01.025. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

152 results

Results by year